Imagine reducing the time to identify a drug that shows results in the clinic to five years: this proof-of-concept study shows how
HUB Organoids official news RSS · 行业原文收录 · 来源发布：Sat Mar 04 2023 01:56:32 GMT+0000 (Coordinated Universal Time) · 本站收录：Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
Patients with mutated KRAS (Kirsten rat sarcoma virus) gene account for around 30-50% of the population with colorectal cancer (CRC) and do not respond to cetuximab, a recognized choice of antibody therapy. A new proof-of-concept study led by the SuppresSTEM European consortium discovers a bispecific antibody that prevents the onset of metastasis and sedates the […] The post Imagine reducing the t
以上为带出处的原文节选，完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。